[1]CurrentPatentAssignee:REMIXTHERAPEUTICS-WO2021/174170,2021,A1Locationinpatent:Page/Pagecolumn197;218
[2]CurrentPatentAssignee:PFIZERINC-WO2016/103097,2016,A1Locationinpatent:Page/Pagecolumn48;49
1216499-22-7
17228-64-7
40851-91-0
34392-85-3
1256808-08-8
1221171-93-2
97-54-1 | Isoeugenol | AA006BNO | MFCD00009285
95538-03-7 | 2,3-Dibromopyrazine | AA006CKB | MFCD02684897
91225-70-6 | 2-(Chloromethyl)-3,5,6,7-tetrahydro-4h-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one | AA006DDU | MFCD00782908
916792-21-7 | 2-Bromo-5-fluoro-4-methylbenzaldehyde | AA006EDR | MFCD07782047
916138-13-1 | 5-(Methoxycarbonyl)thiophene-2-boronic acid, pinacol ester | AA006FJR | MFCD09952057
693222-51-4 | Hymenialdisine Analogue 1 | AA006GBZ | MFCD09840789
915919-60-7 | 1-(3-Aminopropyl)piperidine-3-carboxamide | AA006GTX | MFCD08059829
667413-01-6 | 2-[3-(Trifluoromethyl)phenoxy]propanohydrazide | AA006I2M | MFCD03423122
929973-39-7 | 5-(Chloromethyl)-3-(2-methylpropyl)-1,2,4-oxadiazole | AA006JF4 | MFCD09040567
66018-41-5 | Antibiotic LL Z1640-4 | AA006KXY | MFCD14635375